Stock Price Movement and Market Context
On 22 December 2025, Natraj Proteins recorded its lowest price in the past year at Rs.31.3. This new low comes after a brief period of gains, with the stock rising by 4.01% over the last two days and outperforming its sector by 3.26% today. However, the stock remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating sustained downward pressure over multiple time frames.
In contrast, the broader market has shown resilience. The Sensex opened 216.54 points higher and climbed further by 265.65 points to close at 85,411.55, representing a 0.57% gain. The benchmark index is trading close to its 52-week high of 86,159.02, with its 50-day moving average positioned above the 200-day moving average, signalling a bullish trend. Additionally, the BSE Small Cap index gained 1% today, leading market advances.
Comparative Performance Over One Year
Over the past year, Natraj Proteins has recorded a return of -24.37%, contrasting sharply with the Sensex’s positive return of 9.43% during the same period. The stock’s 52-week high was Rs.51.6, highlighting the extent of the decline to its current low. This underperformance has been consistent, with the stock trailing the BSE500 index in each of the last three annual periods.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Financial Performance and Profitability Metrics
Natraj Proteins’ recent financial results reflect ongoing challenges. For the nine months ended September 2025, net sales stood at Rs.76.54 crores, showing a contraction of 23.59% compared to the previous period. The company reported a PBDIT (Profit Before Depreciation, Interest and Taxes) of Rs.-1.02 crores for the quarter, marking its lowest level. Operating profit as a percentage of net sales for the quarter was -3.79%, indicating a negative margin.
Return on Equity (ROE) averaged 6.97%, signalling modest profitability relative to shareholders’ funds. Meanwhile, the Return on Capital Employed (ROCE) was recorded at 1%, which, while low, corresponds with an enterprise value to capital employed ratio of 0.7. This valuation metric suggests the stock is trading at a discount relative to its capital base and compared to peers’ historical valuations.
Shareholding and Market Capitalisation
The majority of Natraj Proteins’ shares are held by non-institutional investors. The company’s market capitalisation grade is relatively low, reflecting its micro-cap status within the edible oil sector. Despite the subdued market capitalisation, the stock has shown some profit growth of 55.3% over the past year, a factor that contrasts with its price performance.
Considering Natraj Proteins ? Wait! SwitchER has found potentially better options in Edible Oil and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Edible Oil + beyond scope
- - Top-rated alternatives ready
Sector and Industry Positioning
Natraj Proteins operates within the edible oil industry, a sector that has seen mixed performance amid fluctuating commodity prices and evolving consumer demand. While the broader market indices have shown strength, the company’s stock has not mirrored this trend, reflecting sector-specific pressures and company-level factors.
The stock’s current trading below all key moving averages suggests that market participants are cautious, with the price action indicating a lack of upward momentum over short, medium, and long-term horizons.
Summary of Key Price and Performance Indicators
• New 52-week low price: Rs.31.3
• 52-week high price: Rs.51.6
• One-year return: -24.37%
• Sensex one-year return: 9.43%
• Net sales (9M Sep 2025): Rs.76.54 crores, down 23.59%
• PBDIT (Quarter): Rs.-1.02 crores
• Operating profit margin (Quarter): -3.79%
• ROE (average): 6.97%
• ROCE: 1%
• Enterprise value to capital employed: 0.7
The stock’s recent two-day gain of 4.01% and outperformance relative to its sector by 3.26% today provide a short-term counterpoint to the longer-term downtrend. Nonetheless, the prevailing price levels and financial metrics underscore the challenges faced by Natraj Proteins in regaining sustained upward momentum.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
